Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients

Cesar Migliorati

Research output: Contribution to journalComment/debate

5 Citations (Scopus)

Abstract

Article Title and Bibliographic Information: Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. J Oral Maxillofac Surg 2007;65:1328-31. Strength of Recommendation: C. Purpose/Question: To determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time. Source of Funding: American Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund. Type of Study/Design: Retrospective chart review.

Original languageEnglish (US)
Pages (from-to)93-94
Number of pages2
JournalJournal of Evidence-Based Dental Practice
Volume8
Issue number2
DOIs
StatePublished - Jan 1 2008

Fingerprint

Osteonecrosis
Diphosphonates
Jaw
Multiple Myeloma
Prostatic Neoplasms
Breast Neoplasms
Incidence
Medical Schools
Therapeutics
Retrospective Studies
Students
Education
Research

All Science Journal Classification (ASJC) codes

  • Dentistry(all)

Cite this

Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients. / Migliorati, Cesar.

In: Journal of Evidence-Based Dental Practice, Vol. 8, No. 2, 01.01.2008, p. 93-94.

Research output: Contribution to journalComment/debate

@article{7a94a8edecdf46b9add80ba651c0b4db,
title = "Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients",
abstract = "Article Title and Bibliographic Information: Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. J Oral Maxillofac Surg 2007;65:1328-31. Strength of Recommendation: C. Purpose/Question: To determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time. Source of Funding: American Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund. Type of Study/Design: Retrospective chart review.",
author = "Cesar Migliorati",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.jebdp.2008.03.018",
language = "English (US)",
volume = "8",
pages = "93--94",
journal = "Journal of Evidence-Based Dental Practice",
issn = "1532-3382",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients

AU - Migliorati, Cesar

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Article Title and Bibliographic Information: Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. J Oral Maxillofac Surg 2007;65:1328-31. Strength of Recommendation: C. Purpose/Question: To determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time. Source of Funding: American Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund. Type of Study/Design: Retrospective chart review.

AB - Article Title and Bibliographic Information: Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. J Oral Maxillofac Surg 2007;65:1328-31. Strength of Recommendation: C. Purpose/Question: To determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time. Source of Funding: American Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund. Type of Study/Design: Retrospective chart review.

UR - http://www.scopus.com/inward/record.url?scp=43549103523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549103523&partnerID=8YFLogxK

U2 - 10.1016/j.jebdp.2008.03.018

DO - 10.1016/j.jebdp.2008.03.018

M3 - Comment/debate

VL - 8

SP - 93

EP - 94

JO - Journal of Evidence-Based Dental Practice

JF - Journal of Evidence-Based Dental Practice

SN - 1532-3382

IS - 2

ER -